A case report highlights a durable response to the combination of olaparib and PD-1 blockade in a patient with germline PALB2-mutated triple-negative breast cancer and leptomeningeal metastasis. This finding may inform future treatment strategies for similar cases.
durable response to olaparib plus continued pd 1 blockade in germline palb2 mutated triple negative breast cancer with leptomeningeal metastasis a case report
Original title: “Durable response to olaparib plus continued PD-1 blockade in germline PALB2-mutated triple-negative breast cancer with leptomeningeal metastasis: A case report.”